GlassScriptPhysician profile
Dennis Furr
NPI 1093778979
$17,895.25
in general payments reported to CMS, 2019-2025
80 companies · $2,146 in 2025
The $2,146 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,363 · 2020: $2,501 · 2021: $3,364 · 2022: $2,536 · 2023: $2,715 · 2024: $2,269 · 2025: $2,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,130.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,152.08 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,455.49 | 2019-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $1,445.56 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $1,160.46 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $1,056.18 | 2019-2025 | |
| Allergan, INC. | $1,031.98 | 2019-2020 | |
| Amgen INC. | $488.24 | 2019-2025 | Otezla, Repatha, Repatha |
| Amneal Pharmaceuticals LLC | $437.95 | 2019-2025 | Unithroid |
| Janssen Pharmaceuticals, INC | $405.34 | 2019-2025 | Xarelto, Spravato |
| Eisai INC. | $395.57 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $385.26 | 2019-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $376.27 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $374.86 | 2019-2025 | Trintellix |
| Merck Sharp & Dohme LLC | $294.00 | 2019-2025 | Gardasil 9, Dificid, Capvaxive |
| Novartis Pharmaceuticals Corporation | $293.31 | 2019-2025 |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $247.66 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $245.19 | 2019-2024 | |
| Ibsa Pharma INC. | $233.58 | 2019-2025 | Licart, Tirosint, Tirosint |
| Qol Medical, LLC | $224.89 | 2019-2021 | |
| Astellas Pharma US INC | $224.49 | 2019-2025 | Veozah |
| Vanda Pharmaceuticals INC. | $216.88 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $205.88 | 2019-2023 | Airduo Digihaler |
| Optinose US, INC. | $193.74 | 2020-2022 | |
| Biogen, INC. | $177.45 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $168.61 | 2022 | |
| Abbott Laboratories | $153.87 | 2021-2024 | Freestyle Libre 3 |
| Bausch Health US, LLC | $142.10 | 2020-2025 | Wellbutrin, Aplenzin |
| Exact Sciences Corporation | $140.37 | 2023-2025 | Cologuard Collection Kit |
| Antares Pharma, INC. | $137.79 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $133.29 | 2024-2025 | Caplyta |
| Esperion Therapeutics, INC. | $116.49 | 2020-2023 | Nexletol |
| Axsome Therapeutics, INC. | $109.21 | 2023-2025 | Symbravo, Sunosi |
| Exeltis, USA INC. | $107.99 | 2021-2025 | Slynd |
| Sanofi-Aventis U.S. LLC | $103.62 | 2019 | |
| Idorsia Pharmaceuticals US INC | $96.87 | 2023-2024 | Quviviq |
| Sumitomo Pharma America, INC. | $85.87 | 2024-2025 | Gemtesa |
| Currax Pharmaceuticals LLC | $84.74 | 2022-2024 | Contrave, Nexlizet, Nexletol |
| Inspire Medical Systems, INC. | $72.87 | 2023-2024 | Inspire |
| Boston Scientific Corporation | $72.25 | 2021-2023 | |
| Avanir Pharmaceuticals, INC. | $69.36 | 2019-2022 | |
| Acella Pharmaceuticals, LLC | $66.38 | 2024-2025 | NP Thyroid 60 |
| Romark Laboratories, Lc | $65.37 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $58.45 | 2021-2023 | Nuedexta |
| Kowa Pharmaceuticals America, INC. | $56.13 | 2019-2022 | |
| Insightec,INC | $55.31 | 2023 | Exablate |
| Bayer Healthcare Pharmaceuticals INC. | $53.16 | 2023-2025 | |
| Daiichi Sankyo INC. | $52.01 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $50.55 | 2019-2023 | Eliquis |
| Shire North American Group INC | $50.48 | 2019 | |
| Aimmune Therapeutics, INC. | $49.56 | 2025 | Zenpep |
| Aytu Biopharma, INC. | $49.32 | 2019 | |
| Amarin Pharma, INC. | $48.05 | 2019-2021 | |
| Therapeuticsmd, INC. | $46.58 | 2019-2021 | |
| Abiomed | $44.03 | 2024 | Impella |
| Ironwood Pharmaceuticals, INC | $41.18 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $36.89 | 2021 | |
| Alkermes, INC. | $36.76 | 2021 | |
| Medtronic, INC. | $34.87 | 2023 | Intellis Adaptivestim |
| Nestle Healthcare Nutrition INC. | $32.16 | 2021-2022 | |
| Lucid Diagnostics INC. | $30.66 | 2022-2024 | |
| Horizon Therapeutics Plc | $29.16 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $28.58 | 2019 | |
| Corium, LLC | $27.44 | 2022-2023 | Azstarys |
| Brainsway USA INC | $26.95 | 2022 | |
| Hologic Sales and Service, LLC | $25.23 | 2024 | Aptima, Thinprep 2000 Processor |
| Ferring Pharmaceuticals INC. | $24.73 | 2021 | |
| Phathom Pharmaceuticals, INC. | $24.34 | 2024 | Voquezna |
| Cleerly, INC. | $22.02 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Organon LLC | $21.72 | 2023 | Nexplanon |
| Alfasigma USA, INC. | $21.66 | 2022 | |
| Heartflow, INC. | $20.68 | 2025 | |
| Hikma Pharmaceuticals USA | $19.90 | 2019 | |
| Collegium Pharmaceutical, INC. | $19.47 | 2022 | |
| Melinta Therapeutics, LLC | $18.73 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $18.27 | 2019 | |
| Millicent US INC | $17.91 | 2024 | Intrarosa, Femring |
| Inogen, INC. | $15.18 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Vyera Pharmaceuticals, LLC | $14.23 | 2019 | |
| Cequr Corporation | $11.81 | 2024 | Cequr Simplicity |
| Lundbeck LLC | $11.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Furr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.